Sleep Apnea Devices Market Analysis

  • Report ID: 183
  • Published Date: Sep 29, 2025
  • Report Format: PDF, PPT

Sleep Apnea Devices Market Segmentation:

Product Segment Analysis

The therapeutic devices segment is expected to account for a remarkable market share of 76.2% by the end of 2036, owing to growing awareness of the health consequences of sleep apnea, which is leading people to seek early diagnosis and treatment. Companies are also investing in increasing the market accessibility of the therapeutic sleep apnea devices, including PAP, oral, nasal, and other devices. For example, in October 2023, Fisher & Paykel Healthcare Corporation launched the F&P Solo mask in Australia and New Zealand. The product was the very first nasal and pillow mask globally, simplifying the setup process in the treatment of sleep apnea.

Age Group Segmentation Analysis

The 40 to 60 years segment is poised to acquire a significant share by the end of 2036, on account of the higher sleep apnea prevalence. People of this age category are also vulnerable to obesity. As reported in a 2024 report by the National Center for Health Statistics, the prevalence of obesity was higher among adults aged between 40 and 59 from August 2021 to August 2023, compared to people aged 20 to 39 and 60 and over. These facts indicate that individuals from the mentioned age category are highly vulnerable to sleep apnea due to obesity.  

End Use Segment Analysis

The home care settings segment is anticipated to witness significant growth, acquiring a revenue share of 54.2% by the end of 2036, due to the growing demand among patients for personalized treatment options. The continuous launches of the portable, connected, and wearable sleep apnea devices are also influencing the domination of the home care settings segment, allowing users to treat sleep apnea at their own residences. The push by governments, even in developing economies, to accelerate the penetration of digital health is also promoting the use of sleep apnea devices in home-care settings. As reported by the Press Information Bureau in January 2025, through the initiation of campaigns, such as the Ayushman Bharat Digital Mission (ABDM) and the Digital Health Incentive Scheme (DHIS), the government is expected to make the healthcare sector undergo a drastic digital transformation. 

Our in-depth analysis of the global market includes the following segments:

Segments

Subsegments

Product

  • Diagnostic Devices
    • PSG Devices
    • Home Sleep Testing Devices
    • Oximeters
    • Actigraphs
    • Others
  • Therapeutic Devices
    • PAP Devices
    • Oral Devices
    • Accessories
    • Nasal Devices
    • Others
  • Sleep Apnea Masks

Age Group

  • Pediatric
  • Below 40 years
  • 40 to 60 years
  • Above 60 years

Disease Type

  • Obstructive Sleep Apnea Syndrome
  • Central Sleep Apnea Syndrome
  • Complex Sleep Apnea Syndrome

End use

  • Hospitals
  • Home Care Settings
  • Sleep Clinics
  • Ambulatory Care Centers
  • Others

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In 2025, the industry size of the sleep apnea market is over USD 8.9 billion.

The size of the sleep apnea devices market is projected to reach USD 21.4 billion by the end of 2036, expanding at a CAGR of 9.2% during the forecast period, i.e., between 2026-2036.

The major players in the market are ResMed, Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, Inspire Medical Systems, Inc., SomnoMed, and Drive DeVilbiss Healthcare.

The therapeutic devices segment is anticipated to garner the largest market share of 76.2% by 2036 and display lucrative growth opportunities during 2026-2036.

The market in North America is projected to hold the largest market share of 46.7% by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos